AURX Insider Trading Activity and SEC Form 4 Filings
AURX insider trading summary
Over the past 12 months, insiders at Nuo Therapeutics, Inc. (AURX) reported 2 open-market purchases worth $10K by 1 insider and 1 sale worth $300K by 1 insider on SEC Form 4. Net insider selling was $290K.
Latest AURX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 28, 2026 | David Emerson Jorden | CEO/CFO | Buy | $9K (7,984 @ $1.09) |
| Aug 27, 2026 | David Emerson Jorden | CEO/CFO | Buy | $844 (789 @ $1.07) |
| Nov 28, 2025 | David Emerson Jorden | CEO/CFO | Sell | $300K (200,000 @ $1.50) |
| Jul 30, 2025 | Charles E Sheedy | 10% Owner | Buy | $200K (133,333 @ $1.50) |
| Sep 18, 2024 | Charles E Sheedy | 10% Owner | Buy | $94K (125,000 @ $0.75) |
| May 20, 2024 | Charles E Sheedy | 10% Owner | Buy | $75K (100,000 @ $0.75) |
| Dec 19, 2023 | Charles E Sheedy | 10% Owner | Buy | $75K (150,000 @ $0.50) |
| Aug 1, 2023 | Charles E Sheedy | 10% Owner | Buy | $125K (62,500 @ $2.00) |
| Nov 9, 2022 | David Emerson Jorden | CEO/CFO | Sell | $11K (7,000 @ $1.50) |
| Nov 9, 2022 | David Emerson Jorden | CEO/CFO | Sell | $8K (5,000 @ $1.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.